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Background: Endocrine disrupting chemicals (EDCs) present in the environment may disrupt thyroid hormones,
which in early life are essential for brain development. Observational studies regarding this topic are still limited,
however as the presence of chemicals in the environment is ubiquitous, further research is warranted. The objective
of the current study was to assess the association between exposure markers of various EDCs and thyroxine (T4)
levels in newborns in a mother-child cohort in the Netherlands.
Methods: Exposure to dichlorodiphenyldichloroethylene (DDE), three di-2-ethylhexyl phthalate (DEHP) metabolites,
hexachlorobenzene (HCB), polychlorinated biphenyl (PCB)-153, perfluorooctanesulfonic acid (PFOS), and perfluorooctanoic
acid (PFOA) was determined in cord plasma or breast milk, and information on T4 levels in heel prick blood spots was
obtained through the neonatal screening programme in the Netherlands. Linear regression models were composed to
determine associations between each of the compounds and T4, which were stratified for gender and adjusted for a
priori defined covariates.
Results: Mean T4 level was 86.9 nmol/L (n = 83). Girls in the highest quartile of DDE and PFOA exposure
showed an increased T4 level compared to the lowest quartile with both crude and fully adjusted models
(DDE > 107.50 ng/L, +24.8 nmol/L, 95% CI 0.79, 48.75; PFOA > 1200 ng/L, +38.6 nmol/L, 95% CI 13.34, 63.83).
In boys a lower T4 level was seen in the second quartile of exposure for both PFOS and PFOA, however after
fully adjusting the models these associations were attenuated. No effects were observed for the other
compounds.
Conclusion: DDE and perfluorinated alkyl acids may be associated with T4 in a sex-specific manner. These results
should however be interpreted with caution, due to the relatively small study population. More research is
warranted, as studies on the role of environmental contaminants in this area are still limited.
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Thyroid hormones (TH) play a significant role during
development, both during the fetal period as well as
after birth. They are essential for neurodevelopment as
they regulate genes involved in neuronal cell differenti-
ation and myelination [1]. Abnormal TH homeostasis
early in life therefore may have long-term consequences.
Congenital hypothyroidism is the most common cause* Correspondence: m.de.cock@vu.nl
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unless otherwise stated.of mental retardation and is associated with amongst
others high birth weight, deafness, and spasticity [2,3].
Even small changes in maternal thyroid hormones may
affect brain development, as maternal thyroid stimulat-
ing hormone (TSH) is inversely associated with offspring
IQ [4]. Also other outcomes related to thyroid function,
such as birth weight, may be affected by changes in
maternal thyroid hormone levels within the normal
range [5].
Hormones, including thyroid hormones, are sensitive
to external factors such as chemicals which are presentl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
de Cock et al. Environmental Health 2014, 13:106 Page 2 of 10
http://www.ehjournal.net/content/13/1/106in the environment. Exposure to endocrine disrupting
chemicals (EDCs) such as polybrominated diphenyl
ethers (PBDEs), polychlorinated biphenyls (PCBs) and
perfluorinated alkyl acids (PFAAs) have been associated
with effects on TH homeostasis. Prenatal exposure to
PBDE mixture DE-71 in rats has been associated with
reduced T4 levels in both males and females [6,7]. Male
rats prenatally exposed to PBDE and polychlorinated
biphenyls (PCBs), either as a single compound or as a
mixture, also showed reduced T4 levels [8,9]. Similar
results were observed in prenatally exposed female rats
[10]. Also gestational perfluorooctanesulfonic acid (PFOS)
exposure was associated with reduced T4 levels in rats
[11,12]. Human studies on prenatal environmental expo-
sures and thyroid hormones, and T4 in particular, are still
scarce. Prenatal exposure to BDE-100 measured in cord
blood of Taiwanese newborns was associated with an in-
crease in thyroxine/3,5,3′-triiodothyronine (T4/T3) ratio
[13], and also for BDE-154 measured in breast milk a posi-
tive correlation with cord blood log T4 was observed [14].
However, for BDE-99 a decrease in free T4 (fT4) levels
was reported in the same study. Furthermore Kim et al.
[15] observed that cord blood PFOS and perfluoroocta-
noic acid (PFOA) exposure were negatively associated
with cord blood T4 levels [15]. However after adjusting
the models for covariates, most relationships lost signifi-
cance. Also Darnerud et al. who looked at early life ex-
posure to PCBs and DDE in breast milk observed no
associations with thyroid hormones in a population of
Swedish newborns [16].
Results from previous studies are not consistent, and
as neonatal TH levels may depend on various factors
such as birth weight, gestational age, and mode of deliv-
ery, it is important to consider the timing of sampling
[17]. Neonatal screening programs use heel prick blood
spots sampled several days after birth, which is advanta-
geous compared to e.g. cord blood as TH levels may be
less affected by stress of the delivery [18]. The objective
of this study was therefore to assess the association
between exposure markers of various chemicals deter-
mined in cord blood and T4 levels determined as part of
the national neonatal screening programme. For this
purpose data from a newly established mother-child
cohort in the Netherlands was used: the LINC study
(Linking EDCs in maternal nutrition to child health).
The compounds included were dichlorodiphenyldichlor-
oethylene (DDE), polychlorinated biphenyl (PCB)-153,
and hexachlorobenzene (HCB), of which health effects
have been studied frequently, as well as some relatively
‘new’ compounds: metabolites of di(2-ethylhexyl) phtha-
late (DEHP), including mono(2-ethyl-5-carboxypentyl)
phthalate (MECPP), mono(2-ethyl-5-hydroxyhexyl)phthal-
ate (MEHHP), and mono(2-ethyl-5-oxohexyl)phthalate
(MEOHP), as well as PFOS, and PFOA.Materials and methods
Study procedures and subjects
Participants from the LINC study were recruited be-
tween January 2011 and January 2013, through six mid-
wifery clinics in the area of Zwolle in the Netherlands.
The community Zwolle is located in the ‘Salland’ area,
which is characterized by agriculture and stock-breeding
and a relatively low level of urbanization. As only one
hospital is available to serve this community, child births
were relatively easy to track. Women were invited to
participate during the first antenatal visit to the midwife
and were considered eligible for participation if they
were able to fill out Dutch questionnaires. Twin preg-
nancies and major congenital anomalies were reasons
for exclusion, however no participant was excluded be-
cause of these criteria. Signed informed consent was ob-
tained from every participant. Cord blood and breast
milk were collected for determination of markers of
exposure to several endocrine disrupting chemicals. The
national neonatal screening programme was contacted
for data on T4 measured in heel prick blood samples.
Information on birth weight, gestational age, and paren-
tal anthropometry was obtained from the midwives, and
questionnaires were administered during pregnancy to
collect information on parental health and lifestyle, and
previous pregnancies. The study was approved by the
medical ethics committee of the VU University medical
centre in Amsterdam.
Thyroxine
The National Institute for Public Health and the Envir-
onment was approached in order to obtain data on T4
as measured in the neonatal screening programme. Per-
mission from the parents was ascertained for this spe-
cific part of the study. Blood samples were collected on
filter paper through heel puncture which was performed
on average between day 4 and day 7 after birth. Total T4
was determined by means of Autodelfia [19].
Chemical exposure
These methods have been previously published [20].
Umbilical cord blood was collected immediately after
birth when the health of mother and child was ascer-
tained. Midwives and nurses were instructed to collect
as much blood as possible in EDTA tubes through man-
ual expression. The blood was delivered to the lab within
twelve hours by a courier in case of home delivery or by
someone from the hospital staff in case of delivery at the
hospital. At the lab, cord blood was centrifuged for
10 minutes at 2000 g. after which the plasma layer was
transferred to plasma tubes. Plasma was stored at −80°C.
Breast milk was collected in the second month after
birth (mean [SD] weeks after birth: 6.3 [2.5]). In total a
minimum of 100 mL. was collected, spread over five to
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of low milk flow. Mothers were instructed to note the
dates on which they collected a sample and to store the
milk in the freezer in between sampling days. They were
allowed to use a breast pump for collection.
Compounds were analysed in cord plasma. For DDE
and HCB we also analysed breast milk samples from
mothers for whom an insufficient amount of cord blood
was available. PFOA and PFOS were analysed by apply-
ing isotope dilution and large volume injection using an
on-line trapping column coupled to liquid chromatog-
raphy and triple quadropole mass spectrometry. The
breast milk samples were extracted with solid phase
extraction using Oasis WAX cartridges. For the cord
plasma samples, the proteins were precipitated by add-
ing methanol and centrifuging the mixture prior to in-
jection onto the analytical system.
After drying both the cord plasma and the breast milk
samples with Kieselguhr, the organochlorine pesticides
p,p’-DDE, HCB and PCB153 were extracted with a mix-
ture of dichloromethane and hexane. Cleanup of the ex-
tracts was done using sulphuric acid silica columns and
for the analysis gas chromatography with mass spectro-
metric detection in negative chemical ionization mode
was used.
Di-2-ethylhexyl phthalate (DEHP) exposure was ana-
lysed by analysis of three secondary metabolites mono
(2-ethyl-5-carboxypentyl) phthalate (MECPP), mono(2-
ethyl-5-hydroxyhexyl) phthalate (MEHHP), and mono
(2-ethyl-5-oxohexyl) phthalate (MEOHP). Enzymatic
deconjugation was carried out, and after addition of the
internal standards used for isotope dilution, the breast
milk samples were extracted using Oasis MAX cartridges,
while for the cord plasma samples a simple protein pre-
cipitation step using formic acid was applied. The extracts
were analysed after large volume injection using an on-
line trapping column coupled to liquid chromatography
and triple quadropole mass spectrometry. Problems due
to the occurrence of contamination of the breast milk
samples are to be expected for mono(2-ethylhexyl)phthal-
ate (MEHP), the hydrolytic monoester of DEHP, that has
shown to also be formed in the matrix due to the residual
activity of enzymes (lipases, esterases), even after pro-
longed storage periods at −20°C. Therefore, MEHP is a
very unreliable parameter for the assessment of DEHP ex-
posure and should not be used for breast milk. In contrast,
MECPP, MEHHP, and MEOHP are not susceptible to
contamination as they are major metabolites of DEHP cre-
ated by the liver. They are only formed in vivo and serve
as a reliable parameter for DEHP exposure.
The coefficient of variation for the chemicals measured,
was 16 – 17%. More information on chemical analysis,
including limits of quantification and quality control
parameters, is given in Additional file 1, p. 2–4.Covariates
Covariates were selected based on literature [5,21-25]. Each
participant was asked for thyroid gland related health prob-
lems (yes or no) and use of related medication during preg-
nancy (yes or no), by means of questionnaire.
Birth weight was measured after birth by a midwife or
a nurse and data were subsequently obtained from regis-
tries of the midwives. Newborns were put on the weighing
scale without a diaper and birth weight was determined
when the infant was in a calm state. Weighing scales were
provided by the midwives and were calibrated daily.
Weight and length of the mother and father were mea-
sured by the midwife at inclusion, approximately 10–12
weeks in pregnancy. Measurement of maternal weight
was repeated at 36 weeks in pregnancy to determine
gestational weight gain. Midwives received strict instruc-
tions on how to perform these measurements as well as
a measuring tape which was attached to a wall in the
midwife’s office. Weighing scales were provided by the
midwife and were calibrated daily. Gestational age was
determined by midwives by means of ultrasound. Mode
of delivery (caesarean section, yes or no) was recorded
by the midwife.
Questionnaires were administered to collect informa-
tion on birth date of the mother, parity, maternal smok-
ing during the first trimester (yes or no), and alcohol
intake during the first trimester (drinks per week).
Data-analysis
Data analysis was performed using SPSS version 20 [26].
Separate linear regression models were composed for
each compound. To take into account gender-specific
effects of exposure, models were stratified for gender by
means of interaction terms which were added to the
models. For each compound exposure values below the
limit of quantification (LOQ) were replaced by LOQ/√2
[27]. As DDE accumulates in lipid, the following conver-
sion factor was used to transform levels in breast milk to
levels in cord blood [27].
DDE; cord plasma ng=Lð Þ½ 
¼ 1:20 X DDE; breast milk ng=g lipidð Þ½ 
The conversion factor for DDE was based on what has
been published for other European cohorts. For PCB-
153 measured in cord plasma, over 50% of the samples
had an exposure level that was below LOQ. As PCB-153
was determined predominantly in cord blood it was
decided to include PCB-153 as a dichotomous variable
(>LOQ vs. <LOQ). None of the compounds showed a
linear association with T4 levels, therefore each exposure
was split up in quartiles and included as dummy vari-
ables in the model. Models were initially adjusted for
health problems related to the thyroid gland, use of
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Fully adjusted models also included gestational weight
gain, gestational age, parity, smoking, alcohol, maternal
BMI, and maternal age at birth. Each of these covariates
was checked for linearity with T4 and was included in
the models regardless of the degree of confounding. As
gestational weight gain is mostly seen as a confounder
for lipophilic compounds, and as birth weight is consid-
ered to be associated with maternal thyroid hormones,
we performed sensitivity analyses for these variables by
excluding them from the models. The distribution of T4
was checked for normality and outliers by means of his-
tograms. For each model the residuals were plotted and
checked as well for normal distribution. Effect modifica-
tion by smoking was also taken into consideration and
was included if the interaction term was significant
(p < 0.05).Results
In total 148 women were included, of whom 14 subjects
dropped-out. Due to failed sample collection or insuffi-
cient sample volumes, exposure data were not available
for an additional 51 children, resulting in the inclusion
of 83 mother-child pairs for analysis. A description of
the LINC study population is presented in Table 1.
Mean T4 level was 85.6 nmol/L in boys and 89.6 nmol/L
in girls, and mean birth weight was 3632 and 3546
grams in boys and girls respectively. Caesarean section
was performed in 2.4% of births, and maternal thyroid
disease as well as use of related medication was reported
by one participant.Table 1 Population characteristics (n = 83)
Boys (n = 5
Mean ± SD *
T4 (nmol/L) 85.6 ± 20.0
Birth weight (g.) 3632.1 ± 501.5
Gestational age (weeks) 39.7 ± 1.5
Small for gestational age (n) 3 (5.8%)
Large for gestational age (n) 5 (9.6)
Parity (nulliparous, n) 20 (40.0%)
Caesarean (yes, n) 2 (3.8%)
Thyroid disease (yes, n) 0
Thryoid medication (yes, n) 0
BMI mother (start pregnancy, kg/m2) 23.7 ± 3.4
Gestational weight gain (kg.) 12.7 ± 4.2
Age mother (years) 33.0 ± 4.9
Smoking (first trimester, yes, n) 2 (3.8%)
Alcohol (yes, n) 2 (3.8%)
*Values are mean ± SD unless stated otherwise.An overview of exposure levels of various compounds
in cord plasma as well as breast milk is given in Table 2.
For PCB-153, DDE, and HCB, wet weight levels in breast
milk were significantly higher than in cord plasma. How-
ever, lipid adjusted levels were similar, reflecting the high
fat content of the breast milk. For these compounds the
percentage of samples with exposure levels above the
LOQ was also higher in breast milk than in cord blood.
Concentrations of HCB in cord blood were < LOQ in
more than 98% of the samples. Therefore HCB was not
included in the analysis.
All three DEHP metabolites as well as the PFAAs had
relatively high quantification rates. In contrast to what
was observed for PCB-153, DDE, and HCB, levels of
PFOS and PFOA were higher in cord plasma compared
to breast milk.
Associations with T4 were observed for total DDE,
PFOS, and PFOA, depending on the sex of the infant
(Tables 3 and 4). Girls in the highest quartile of total
DDE exposure showed significantly increased T4 levels
compared to the lowest exposed group for crude as well
as adjusted analyses, while for boys no difference in T4
levels were detected across quartiles. Boys in the second
and third quartile of PFOS exposure had significantly
lower T4 levels than the reference group with the crude
model (respectively −22.1 nmol/L, 95% CI: −38.75
to −5.48; and −16.8 nmol/L, 95% CI −33.47 to −0.21).
After partially adjusting the model, only the second
quartile remained significantly lower than the reference
group, but in the fully adjusted model also this associ-
ation disappeared. In girls no effect of PFOS exposure
on T4 levels was observed, however for PFOA the2) Girls (n = 31)
Min - max Mean ± SD* Min - max
42 - 138 89.6 ± 14.9 68 – 117
2130 – 4950 3546.3 ± 397.6 2710 – 4350
34.1 – 41.6 40.1 ± 1.0 36.6 – 42.0
1 (3.3)
2 (6.7)
0 – 4 10 (32.3%) 0 – 3
- 0 -
- 1 (3.3) -
- 1 (3.3) -
17.8 – 32.5 23.0 ± 4.3 18.8 – 36.5
1.0 – 23.0 12.1 ± 5.3 −6.0 – 20.0
23.0 – 40.0 32.0 ± 3.4 23 – 36
- 2 (6.5%) -
- 2 (6.5%) -
Table 2 Exposure levels in cord plasma and/or breast milk
Compound N Mean Median Range LOQ <LOQ (%)
PCB-153
Cord plasma - ng/L 51 35.40 28.28 22.63 – 96.00 21 – 43 57.7
- ng/g lipid 51 36.02 30.00 17.95 – 88.89 14 – 53 57.7
DDE
Cord plasma - ng/L 51 114.48 79.00 37.48 – 470.00 33 – 73 23.1
- ng/g lipid 51 115.98 81.97 28.83 – 580.25 23 – 86 23.1
Breast milk - ng/L 24 2379.58 1895.00 400.00 – 11390.00 9.20 – 13.00 0
- ng/g lipid 24 59.20 44.10 12.11 – 277.80 0.13 – 0.53 0
Totala - ng/L 75 100.70 74.50 14.53 – 470.00
HCB
Cord plasma - ng/L 51 44.33 44.55 28.28 – 78.00 40 – 79 98.1
- ng/g lipid 51 46.23 45.85 27.27 – 82.11 25 – 96 98.1
Breast milk - ng/L 24 622.92 655.00 300.00 – 1060.00 9.20 – 13.00 0
- ng/g lipid 24 15.94 14.94 10.65 – 25.85 0.16 – 0.68 0
MECPP
Cord plasma - ng/mL 64 0.31 0.27 0.11 – 1.00 0.13 – 0.28 7.8
MEHHP
Cord plasma - ng/mL 64 0.33 0.27 0.10 – 1.00 0.14 – 0.27 9.4
MEOHP
Cord plasma - ng/mL 64 0.29 0.23 0.12 – 0.87 0.17 – 0.33 25.0
PFOA
Cord plasma - ng/L 64 943.44 885 200 – 2700 50 – 140 0
PFOS
Cord plasma - ng/L 64 1616.88 1600 570 – 3200 44 – 140 0
aFor total DDE, cord plasma exposure data were merged with breast milk exposure levels converted to cord plasma levels.
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with the crude as well as the adjusted models. Mean T4
levels were 22.8 nmol/L (95% CI 0.86 to 44.79) higher
compared to the reference group when no adjustments
for covariates were made. This difference increased to
38.6 nmol/L (95% CI: 13.34 to 63.83) in the fully ad-
justed model. In boys no effect of PFOA exposure on T4
was observed, except for the second quartile of expos-
ure, which had a significantly lower T4 level than
the reference group (−20.3 nmol/L, 95% CI: −37.29
to −3.24). However, the adjusted analyses showed atten-
uated and even opposite associations that were no lon-
ger statistically significant. No significant associations
with T4 were observed for the DEHP metabolites and
for PCB-153 (Table 5). Removing birth weight or gesta-
tional weight gain from the models did not affect the
results (not shown).
Discussion
The objective of the current study was to investigate the
association between prenatal exposure to various endo-
crine disrupting chemicals measured in cord blood andbreast milk, and T4 levels determined in heel prick
blood spots. Girls in the highest quartile of DDE and
PFOA exposure showed increased T4 levels compared
to the lowest quartile, a difference which remained
significant after fully adjusting the model for covariates.
For PFOA, the highest exposed group of girls had a
mean T4 level which was 38.6 nmol/L higher than the
reference group, a difference which is quite large consid-
ering that the range in T4 values in this cohort was
96 nmol/L. In boys a lower T4 level was seen in the
second quartile of exposure for both PFOS and PFOA,
however after adjusting the models, these associations
attenuated and were no longer significant. For the DEHP
metabolites as well as for PCB no association with T4
was observed in either boys or girls.
The positive association between DDE exposure and
T4 in the highest exposed quartile of girls is not in line
with what has been reported in other observational stud-
ies [16,28,29], which either report no association or an
inverse association. It should be noted that Maervoet
et al. and Asawasinsopon et al. determined fT4 or T4 in
cord blood, which may have confounded their results as
Table 3 Regression coefficients for various exposures in boys (in quartiles) and T4 (nmol/L)
N Q1 Q2 Q3 Q4
Compound β (95% CI) p-value β (95% CI) p-value β (95% CI) p-value
DDE (Total, ng/L) <41.80 41.80 – 74.50 74.51 – 107.50 >107.50
Crude 70 Ref −2.1 (−17.33, 13.23) 0.789 −8.5 (−23.51, 6.43) 0.258 2.1 (−12.27, 16.42) 0.773
Model A1 65 Ref −3.3 (−20.00, 13.33) 0.690 −6.6 (−22.60, 9.31) 0.407 2.8 (−12.05, 17.58) 0.710
Model B2 61 Ref 10.5 (−13.94, 34.90) 0.389 2.9 (−17.00, 22.71) 0.771 8.0 (−10.68, 26.77) 0.389
MECPP (ng/mL) <0.22 0.22 – 0.27 0.28 – 0.38 >0.38
Crude 63 Ref −1.8 (−18.34, 14.65) 0.823 −4.9 (−21.73, 12.00) 0.565 9.3 (−7.97, 26.63) 0.284
Model A1 57 Ref −3.2 (−21.01, 14.61) 0.719 −6.8 (−25.19, 11.50) 0.456 9.6 (−9.30, 28.56) 0.311
Model B2 52 Ref −18.2 (−37.96, 1.62) 0.070 −12.3 (−34.98, 10.37) 0.257 −4.2 (−26.88, 18.51) 0.708
MEHHP (ng/mL) <0.18 0.18 – 0.27 0.28 – 0.39 >0.39
Crude 63 Ref −4.0 (−21.73, 13.73) 0.653 −3.1 (−22.87, 16.77) 0.758 2.7 (−16.20, 21.54) 0.777
Model A1 57 Ref −1.9 (−21.06, 17.23) 0.841 −1.7 (−22.42, 19.11) 0.873 7.8 (−12.74, 28.36) 0.448
Model B2 52 Ref −2.4 (−26.23, 21.51) 0.841 1.3 (−24.08, 26.60) 0.919 4.6 (−22.28, 31.50) 0.728
MEOHP (ng/mL) <0.17 0.17 – 0.23 0.24 – 0.41 >0.41
Crude 63 Ref 15.2 (−2.37, 32.71) 0.089 8.8 (−9.37, 26.97) 0.336 12.2 (−5.97, 30.37) 0.184
Model A1 57 Ref 13.6 (−4.66, 31.95) 0.140 7.9 (−10.50, 26.30 0.392 15.9 (−2.98, 34.75) 0.097
Model B2 52 Ref 3.8 (−19.48, 27.16) 0.738 −6.1 (−31.51, 19.31) 0.626 −1.8 (−26.20, 22.58) 0.880
PFOS (ng/L) <1026 1026 – 1600 1601 – 2175 >2175
Crude 62 Ref −22.1* (−38.75, −5.48) 0.010 −16.8* (−33.47, −0.21) 0.047 −11.8 (−29.14, 5.64) 0.181
Model A1 57 Ref −22.8* (−39.83, −5.83) 0.010 −18.0 (−36.84, 0.79) 0.060 −13.9 (−31.56, 3.81) 0.121
Model B2 52 Ref −7.9 (−31.56, 15.74) 0.499 −16.5 (−40.32, 7.34) 0.167 −9.6 (−32.57, 13.31) 0.396
PFOA (ng/L) <591 591 – 865 866 – 1200 >1200
Crude 62 Ref −20.3* (−37.29, −3.24) 0.021 −12.2 (−27.15, 2.80) 0.109 −11.3 (−28.29, 5.80) 0.190
Model A1 57 Ref −16.8 (−35.09, 1.54) 0.072 −7.7 (−23.93, 8.46) 0.341 −9.2 (−27.09, 8.79) 0.310
Model B2 52 Ref 7.9 (−18.04, 33.92) 0.536 −2.1 (−20.94, 16.78) 0.823 6.2 (−16.08, 28.50) 0.572
1Adjusted for thyroid gland problems, use of thyroid medication, and birth weight. Caesarean section was constant and not included in the model.
2Model A + additionally adjusted for gestational weight gain, gestational age, parity, smoking, alcohol, maternal BMI, and maternal age at birth.
*p < 0.050.
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may have been elevated due to stress of the delivery
(median total T4 level in the study of Asawasinsopon
et al. was 111.3 nmol/L). Furthermore DDE levels were
higher in both these cohorts (189 ng/g lipid and 742 ng/g
lipid for Maervoet et al. and Asawasinsopon respectively).
Also in animal studies disruption of TH by DDE is
reported, although generally also an inverse association is
observed [30,31]. However, due to the relatively small
study population with less than 40% girls, results of the
current study should also be interpreted with caution. As
limited data on the effect of intra-uterine exposure to
EDCs on thyroid function in newborns are available, and
as results thus far are equivocal, more research is war-
ranted to clarify dose–response associations between pre-
natal DDE exposure and T4 in newborns.
Levels of PFOS and PFOA observed in this study
population were relatively low compared to what has
been reported for other birth cohorts [15,32-34]. Withthe exception of Kim et al. [15], none of these studies
determined associations between exposure and thyroid
hormone levels. Kim et al. observed no associations be-
tween cord blood PFOS or PFOA concentrations and T4
or TSH in the newborn. Concentrations of exposures were
similar to the current study, however analyses were not
stratified for gender, which may explain discrepancies with
our results. We observed that girls with a relatively high
PFOA exposure had a T4 level which was significantly
higher than their peers with low exposure. These gender
dimorphic associations have also been seen by Knox et al.
[35], who determined PFOS and PFOA in serum of adults
and found both compounds to be associated with in-
creases in serum T4 [35]. They furthermore observed gen-
der specific interactions for PFOS, but not PFOA, and T4,
with women having higher T4 levels than men across all
quartiles of exposure.
The differences in T4 levels for PFOA exposure in girls
are relevant as they may potentially have implications for
Table 4 Regression coefficients for various exposures in girls (in quartiles) and T4 (nmol/L)
n Q1 Q2 Q3 Q4
Compound β (95% CI) p-value β (95% CI) p-value β (95% CI) p-value
DDE (Total, ng/L) <41.80 41.80 – 74.50 74.51 – 107.50 >107.50
Crude 70 Ref 0.7 (−16.17, 17.48) 0.938 3.9 (−14.66, 22.47) 0.675 20.2* (1.59, 38.71) 0.034
Model A1 65 Ref 3.0 (−14.66, 20.69) 0.734 2.3 (−17.14, 21.80) 0.811 24.4* (2.30, 46.47) 0.031
Model B2 61 Ref 8.7 (−10.00, 27.45) 0.350 8.6 (−13.00, 30.18) 0.424 24.8* (0.79, 48.75) 0.043
MECPP (ng/mL) <0.22 0.22 – 0.27 0.28 – 0.38 >0.38
Crude 63 Ref −1.6 (−22.55, 19.30) 0.877 −12.0 (−36.62, 12.62) 0.333 11.3 (−13.37, 35.87) 0.363
Model A1 57 Ref 3.4 (−18.62, 25.37) 0.759 −10.3 (−38.03, 17.52) 0.461 16.3 (−11.69, 44.36) 0.247
Model B2 52 Ref 6.2 (−24.71, 37.04) 0.685 −14.5 (−45.49, 16.44) 0.344 14.0 (−14.01, 42.07) 0.314
MEHHP (ng/mL) <0.18 0.18 – 0.27 0.28 – 0.39 >0.39
Crude 63 Ref −9.3 (−34.00, 15.47) 0.456 −8.0 (−28.68, 12.68) 0.441 −3.2 (−30.24, 23.91) 0.815
Model A1 57 Ref −7.8 (−35.52, 20.00) 0.575 −8.1 (−29.95, 13.66) 0.456 −1.5 (−29.50, 26.41) 0.912
Model B2 52 Ref −5.7 (−49.41, 38.11) 0.793 −11.2 (−35.27, 12.94) 0.350 −0.4 (−30.20, 29.43) 0.979
MEOHP (ng/mL) <0.17 0.17 – 0.23 0.24 – 0.41 >0.41
Crude 63 Ref −10.5 (−32.11, 11.08) 0.333 6.6 (−18.83, 32.07) 0.604 −10.2 (−30.73, 10.30) 0.322
Model A1 57 Ref −12.8 (−36.53, 10.91) 0.283 2.5 (−30.01, 34.94) 0.879 −9.7 (−32.80, 13.37) 0.401
Model B2 52 Ref −19.6 (−47.55, 8.30) 0.161 1.6 (−35.19, 38.30) 0.932 −12.5 (−40.01, 19.92) 0.357
PFOS (ng/L) <1026 1026 – 1600 1601 – 2175 >2175
Crude 62 Ref −3.3 (−24.28, 17.65) 0.752 −2.7 (−27.42, 22.00) 0.826 9.5 (−10.46, 29.37) 0.345
Model A1 57 Ref 2.3 (−21.13, 25.69) 0.845 −1.4 (−27.00, 24.17) 0.912 10.2 (−10.90, 31.24) 0.336
Model B2 52 Ref −1.3 (−30.45, 27.94) 0.930 4.5 (−25.95, 34.92) 0.766 15.9 (−10.67, 42.40) 0.231
PFOA (ng/L) <591 591 – 865 866 – 1200 >1200
Crude 62 Ref −3.6 (−23.09, 15.90) 0.713 2.6 (−19.40, 24.54) 0.815 22.8* (0.86, 44.79) 0.042
Model A1 57 Ref −1.5 (−22.39, 19.40) 0.886 11.3 (−14.23, 36.79) 0.378 27.8* (5.03, 50.64) 0.018
Model B2 52 Ref −5.9 (−26.75, 14.94) 0.566 11.8 (−19.08, 42.72) 0.439 38.6* (13.34, 63.83) 0.004
1Adjusted for thyroid gland problems, use of thyroid medication, and birth weight. Caesarean section was constant and not included in the model.
2Model A + additionally adjusted for gestational weight gain, gestational age, parity, smoking, alcohol, maternal BMI, and maternal age at birth.
*p < 0.05
Table 5 Regression coefficients for PCB-153
(<LOQ vs. >LOQ) and T4 (nmol/L), stratified for gender
N <LOQ >LOQ
β (95% CI) P-value
Male
Crude 48 Ref. 3.3 (−9.58, 16.20) 0.607
Model A1 45 Ref. 4.2 (−9.63, 18.05) 0.542
Model B2 42 Ref. −0.6 (−19.02, 17.79) 0.945
Female
Crude 48 Ref. −4.5 (−22.54, 13.55) 0.618
Model A1 45 Ref. −7.4 (−28.59, 13.78) 0.483
Model B2 42 Ref. −17.2 (−43.52, 9.04) 0.188
1Adjusted for thyroid gland problems, use of thyroid medication, and birth
weight. Caesarean section was constant and not included in the model.
2Model A + additionally adjusted for gestational weight gain, gestational age,
parity, smoking, alcohol, maternal BMI, and maternal age at birth.
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and high TSH levels within the normal range were associ-
ated with symptoms of attention deficit hyperactivity
disorder (ADHD) in four year olds [36]. A similar obser-
vation was made in subjects with resistance to thyroid
hormone, in whom total T4 concentrations correlated
positively with symptoms of hyperactivity [37]. Though
the study by Alvarez-Pedrerol et al. was a cross-sectional
study, the association between symptoms of ADHD and
thyroid hormones in the normal range may be an indica-
tion of the sensitivity of the process of neurodevelopment
at young age. None of the subjects in the current study
had deviating or dubious T4 levels according to the cut-
offs used in the Dutch neonatal screening program [38]. It
would be interesting to follow these children up at later
age to see if there is a relation between early life expos-
ure and prevalence of neurodevelopmental disorders,
and if so, if these associations are mediated by thyroid
hormones.
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may displace T4 from binding proteins such as albumin
[39-41] or transthyretin [42], which would result in an
increase in fT4 and a subsequent decrease in T4, oppos-
ite from our observations. This has been however pre-
dominantly shown in vitro. In vivo studies are few, and
it has furthermore been suggested that animals react dif-
ferently to endocrine disrupting chemicals, either having
a higher tolerance [43], as well as having a TH status
more sensitive to exogenous compounds [44]. It would
therefore be very interesting to measure both T4 and
thyroid binding proteins in humans, however this infor-
mation was not available in the current study. Further
research is required to elucidate how PFAAs interact
with thyroid hormones.
Data within this cohort was collected prospectively,
and though small, this study population was very
homogenous as all women were of Dutch origin and the
majority was high educated (64% having a bachelor or
master degree). Associations are therefore less likely to
be confounded by demographic or socio-economic fac-
tors. Covariates were carefully selected based on lite-
rature, however the association between fetal T4 and
gestational weight gain has not been reported on fre-
quently, which might make inclusion of this variable in
the models questionable. However in a recently pub-
lished study by Pop et al. [25], fetal fT4 concentrations
were associated with high weight gain during pregnancy
[45]. Furthermore Verner et al. [46] reported that gesta-
tional weight gain is associated with lipophilic compounds
in particular, implying that it should be considered as a
potential confounder. Also birth weight was included as a
covariate, however associations between birth weight and
thyroid hormones have mainly been reported for maternal
as opposed to offspring thyroid hormones. We therefore
performed sensitivity analysis by excluding both variables
independently from the models, which did not affect re-
sults. We furthermore did not adjust our analysis for time
of heel prick sampling, which was done between 4–7 days
after birth. T4 levels peak at 24 hours after birth and
decrease slowly over the following days [47]. Even though
changes in T4 levels are small during the period heel prick
samples are collected, this may have obscured effects or
may have resulted in non-relevant findings.
The sample size in this study was small, and power
was reduced by dividing subjects in quartiles based on
exposure, which was necessary as there was no linear as-
sociation between outcome and exposure. Moreover re-
sults were stratified for gender, and models were adjusted
for several confounders, which also reduced power of the
tests. Pooling the children into one group and not stratify-
ing for gender was considered, however as these com-
pounds are known to disrupt the endocrine system, which
is gender-specific in itself, it was decided to performstratified analysis. Though there are no indications we
know of for gender-specific effects regarding disruption of
thyroid hormones, our results only showed effects for
girls. As the standard errors of the models were not af-
fected after stratification, it was decided to present results
separately for boys and girls. We have not used correc-
tions for multiple testing, such as a Bonferroni correction,
because this would further reduce the power of our statis-
tical tests, but we are aware that some of the findings may
be false positive findings.
The small sample size was partly due to 51 partici-
pants for whom no samples or insufficient volumes of
cord blood were available. Most of the participants gave
birth at home, and collection of cord blood was not al-
ways possible due to emergency transport to the hospital
where the participants were referred to the obstetrician,
or errors occurred in transport of samples to the labora-
tory. For some participants no breast milk was available,
as not all children received breast feeding.
DDE levels determined in milk samples, approximately
one third of samples, were converted to cord blood
values by means of a factor derived from what has been
previously published in a meta-analysis of twelve birth
cohorts. Though there is no standard conversion factor,
we considered this the best option as it was based on co-
horts from Europe. Nonetheless, it may have attenuated
associations.
No associations between PCB-153 and T4 were ob-
served in both boys and girls. This was in line with a
similar study in a Canadian birth cohort, despite their
relatively high exposure to this compound [48]. On the
other hand, an inverse association between fT4 and
PCB-153 was reported for a Belgian cohort, in which
exposure levels were comparable to levels in our study
population [28]. It must be noted that for both the
Belgian and the Canadian cohort, thyroid hormones
were determined in cord blood, and comparison of
results for PCB-153 is therefore complicated. Also for
each of the DEHP metabolites no effects on T4 were
observed. Exposure was determined in cord blood and
breast milk, which is relatively novel as in most studies
urine is used. We were able to quantify levels in the
majority of the samples, as the LOQ was very sensitive
and in some samples as low as 0.13 ng/mL, compared to
a limit of detection of 0.2 ng/mL which was for example
reported by Olsén et al. who determined DEHP metabo-
lites in serum of elderly people in Sweden [49]. Though
there are several studies in adults, only one study is
available which related serum T4 levels to phthalate
levels in urine of four to nine year old children [50]. No
effect of exposure on T4 was reported, however, various
phthalates showed a positive association with levels of
free and total T3, indicating that phthalates may poten-
tially also interact with TH. Experimental evidence for
de Cock et al. Environmental Health 2014, 13:106 Page 9 of 10
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is widespread, future studies should aim to include
these compounds when investigating the effect of
environmental exposures on thyroid function.
Conclusions
This study showed that DDE and PFAAs may be associ-
ated with T4 in a sex-specific manner. The study popula-
tion was relatively small, therefore results should be
interpreted with caution, and confirmation from larger
studies is warranted. Thyroid hormones are very import-
ant during developmental stages in life, and even subtle
changes may have an impact on child health. More
research is warranted, as studies on the role of environ-
mental contaminants in this area are still limited.
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